Improving diabetes care by involving patients and their caregivers in secure messaging.
Promoting Safety by Engaging Diverse Diabetes Patients and their Caregivers in Secure Messaging
This study is looking at how using secure messaging tools can help people with type 2 diabetes and their caregivers work together better to manage the condition, aiming to improve treatment and health outcomes.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10890660 on NIH RePORTER |
What this research studies
This research focuses on enhancing diabetes management by engaging both patients and their caregivers through secure messaging platforms. The project aims to develop technology-based communication interventions that facilitate better understanding and collaboration in chronic disease care. By utilizing patient portals, the research seeks to improve adherence to treatment, disease control, and overall safety outcomes for individuals with type 2 diabetes. The study will also incorporate training in data analytics and implementation science to ensure effective application of the findings.
Who could benefit from this research
Good fit: Ideal candidates for this research are diverse patients with type 2 diabetes and their caregivers who are willing to engage in secure messaging for health management.
Not a fit: Patients without diabetes or those who do not have caregivers involved in their care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management and health outcomes for patients through better communication with their caregivers.
How similar studies have performed: Previous research has shown that engaging caregivers in chronic disease management through technology can lead to improved patient outcomes, indicating a promising approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Semere, Wagahta — University of California, San Francisco
- Study coordinator: Semere, Wagahta
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.